Childhood cancer survivors may benefit from early MRI breast cancer screening.
Early MRI-based breast cancer screening of females treated with radiation therapy for childhood cancer can reduce breast cancer mortality in this patient group, according to a study published in the Journal of the National Cancer Institute.
Researchers from Canada sought to determine the benefit of early breast cancer screening of female childhood cancer survivors who had undergone thoracic radiation therapy (RT). The researchers searched through published studies that reviewed the risk of breast cancer in survivors of childhood lymphoma, and used a mathematical model of breast cancer development to quantify the effectiveness of screening starting at age 25 among women who had undergone chest RT as children.
The results showed that overall, survivors who were 15 years old when they received RT had an absolute risk of 16.65 percent of BC mortality by age 75 years. However, this risk decreased with regular screening:
“Approximately 80 patients would need to be invited to MRI-based screening to prevent one BC death,” the authors wrote. Combining MRI and mammography would likely produce 99.52 false positives per 1,000 screenings of women between 25 and 39 years.
"If you are a young woman who was treated with radiation therapy to your chest as a teenager or child for [Hodgkin’s lymphoma], or for that matter chest radiation therapy for any reason, you should be having a conversation with your family doctor or your oncologist about whether to start breast cancer screening earlier than most women would," principal investigator David Hodgson, MD, professor in the department of radiation oncology, faculty of medicine, University of Toronto, said in a release.
Because of the increased risk of false positives in this age group, Hodgson said in the release: This is important for patients to know and for physicians to counsel patients about because it's stressful for a patient to be called back about suspicious findings.
The researchers concluded that early breast cancer screening with MRI for women who received RT for childhood cancers is beneficial and will reduce breast cancer mortality.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.